News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,120 Results
Type
Article (62766)
Company Profile (88)
Press Release (672256)
Multimedia
Podcasts (164)
Webinars (26)
Section
Business (198775)
Career Advice (3042)
Deals (34884)
Drug Delivery (131)
Drug Development (82712)
Employer Resources (176)
FDA (16556)
Job Trends (15185)
News (342286)
Policy (33220)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2799)
Academic (2)
Accelerated approval (39)
Adcomms (31)
Allergies (160)
Alliances (49624)
ALS (181)
Alzheimer's disease (1704)
Antibody-drug conjugate (ADC) (338)
Approvals (16826)
Artificial intelligence (605)
Autoimmune disease (187)
Automation (46)
Bankruptcy (318)
Best Places to Work (11678)
BIOSECURE Act (19)
Biosimilars (200)
Biotechnology (64)
Bladder cancer (175)
Brain cancer (66)
Breast cancer (665)
Cancer (5125)
Cardiovascular disease (440)
Career advice (2599)
Career pathing (42)
CAR-T (302)
CDC (59)
Celiac Disease (2)
Cell therapy (822)
Cervical cancer (38)
Clinical research (70658)
Collaboration (1845)
Company closure (5)
Compensation (849)
Complete response letters (69)
COVID-19 (2750)
CRISPR (107)
C-suite (960)
Cystic fibrosis (150)
Data (6583)
Decentralized trials (2)
Denatured (59)
Depression (142)
Diabetes (519)
Diagnostics (6858)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (290)
Drug pricing (205)
Drug shortages (29)
Duchenne muscular dystrophy (240)
Earnings (80539)
Editorial (66)
Employer branding (21)
Employer resources (157)
Events (114342)
Executive appointments (1062)
FDA (19870)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (26)
Funding (1556)
Gene editing (221)
Generative AI (60)
Gene therapy (650)
GLP-1 (1040)
Government (5063)
Grass and pollen (8)
Guidances (385)
Healthcare (19430)
HIV (71)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (261)
Immuno-oncology (69)
Indications (133)
Infectious disease (3038)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (128)
Intellectual property (262)
Interviews (582)
IPO (16018)
IRA (52)
Job creations (3859)
Job search strategy (2138)
JPM (67)
Kidney cancer (20)
Labor market (84)
Layoffs (619)
Leadership (42)
Legal (7950)
Liver cancer (96)
Longevity (17)
Lung cancer (688)
Lymphoma (386)
Machine learning (45)
Management (60)
Manufacturing (841)
MASH (176)
Medical device (13990)
Medtech (14053)
Mergers & acquisitions (20025)
Metabolic disorders (1352)
mRNA (177)
Multiple sclerosis (168)
NASH (17)
Neurodegenerative disease (341)
Neuropsychiatric disorders (93)
Neuroscience (3017)
Neurotech (1)
NextGen: Class of 2026 (6841)
Non-profit (4804)
Now hiring (22)
Obesity (636)
Opinion (325)
Ovarian cancer (167)
Pain (224)
Pancreatic cancer (244)
Parkinson's disease (300)
Partnered (34)
Patents (533)
Patient recruitment (550)
Peanut (65)
People (62496)
Pharmaceutical (23)
Pharmacy benefit managers (32)
Phase 1 (21936)
Phase 2 (30920)
Phase 3 (23114)
Pipeline (5975)
Policy (317)
Postmarket research (2905)
Preclinical (9546)
Press Release (66)
Prostate cancer (267)
Psychedelics (46)
Radiopharmaceuticals (306)
Rare diseases (935)
Real estate (6337)
Recruiting (74)
Regulatory (24956)
Reports (49)
Research institute (2529)
Resumes & cover letters (466)
Rett syndrome (31)
RNA editing (17)
RSV (80)
Schizophrenia (152)
Series A (269)
Series B (187)
Service/supplier (9)
Sickle cell disease (105)
Special edition (24)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3517)
State (1)
Stomach cancer (17)
Supply chain (108)
Tariffs (75)
The Weekly (103)
Vaccines (1067)
Venture capital (87)
Weight loss (418)
Women's health (97)
Worklife (23)
Date
Today (158)
Last 7 days (800)
Last 30 days (2985)
Last 365 days (30274)
2026 (5297)
2025 (30534)
2024 (34547)
2023 (38959)
2022 (49831)
2021 (54826)
2020 (53803)
2019 (47852)
2018 (36287)
2017 (33172)
2016 (33024)
2015 (38661)
2014 (32404)
2013 (28568)
2012 (29974)
2011 (29908)
2010 (28882)
Location
Africa (991)
Alabama (91)
Alaska (7)
Arizona (269)
Arkansas (15)
Asia (42676)
Australia (7480)
California (11175)
Canada (3294)
China (1163)
Colorado (491)
Connecticut (509)
Delaware (344)
Europe (99551)
Florida (1701)
Georgia (382)
Hawaii (3)
Idaho (61)
Illinois (930)
India (76)
Indiana (539)
Iowa (20)
Japan (445)
Kansas (122)
Kentucky (46)
Louisiana (32)
Maine (77)
Maryland (1405)
Massachusetts (8107)
Michigan (351)
Minnesota (608)
Mississippi (7)
Missouri (141)
Montana (35)
Nebraska (26)
Nevada (127)
New Hampshire (81)
New Jersey (3131)
New Mexico (32)
New York (3048)
North Carolina (1517)
North Dakota (9)
Northern California (5432)
Ohio (338)
Oklahoma (23)
Oregon (42)
Pennsylvania (2247)
Puerto Rico (23)
Rhode Island (45)
South America (1344)
South Carolina (68)
South Dakota (1)
Southern California (4440)
Tennessee (188)
Texas (1788)
United States (40527)
Utah (358)
Vermont (1)
Virginia (271)
Washington D.C. (76)
Washington State (914)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
735,120 Results for "american society of cataract and refractive surgery".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
April 23, 2025
·
9 min read
BioForest
Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Aurion Biotech today announced several presentations during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston, Massachusetts.
April 2, 2024
·
3 min read
Biotech Beach
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos Corporation announced today that it will present multiple scientific abstracts at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 5-8, 2024 in Boston, MA.
April 1, 2024
·
9 min read
Press Releases
Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
March 3, 2026
·
7 min read
Genetown
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”) announced multiple scientific presentations at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting being held April 5-8 in Boston, Massachusetts.
March 26, 2024
·
3 min read
Biotech Beach
ViaLase to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it will present clinical data as well as provide a business and technology overview during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston, Massachusetts.
April 2, 2024
·
3 min read
Drug Development
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
Ocular Therapeutix, Inc. announced positive Phase 2 data for PAXTRAVA in patients with open-angle glaucoma or ocular hypertension The data are being presented by Mark Gallardo, MD during the 2024 American Society of Cataract and Refractive Surgery Annual Meeting.
April 6, 2024
·
12 min read
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced fifteen podium and four poster presentations during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, which will take place in Boston, April 5-8, 2024.
March 27, 2024
·
14 min read
Press Releases
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
April 22, 2025
·
7 min read
Drug Development
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
OKYO Pharma Limited announced an upcoming presentation of the OK-101 Phase 2 data for dry eye disease at Eyecelerator 2024, a partner meeting of the American Society of Cataract and Refractive Surgery Annual Meeting, being held April 4, 2024 in Boston, MA.
April 2, 2024
·
2 min read
1 of 73,512
Next
